Similar articles

• Is there a problem with ezetimibe or just ENHANCEd hype?

  Whayne TF Jr. Whayne TF Jr. Angiology. 2008 Dec-2009 Jan;59(6):661-3. doi: 10.1177/0003319708321188. Epub 2008 Sep 15. Angiology. 2008. PMID: 18796445 No abstract available.
• Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.

  Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. Katsiki N, et al. Int Angiol. 2011 Jun;30(3):295; author reply 296. Int Angiol. 2011. PMID: 21617615 No abstract available.
• After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.

  Mascitelli L, Ravnskov U, Pezzetta F, Goldstein MR. Mascitelli L, et al. Angiology. 2009 Feb-Mar;60(1):127-8; author reply 129-30. doi: 10.1177/0003319708327788. Epub 2008 Dec 1. Angiology. 2009. PMID: 19049996 No abstract available.
• ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].

  Olsson AG, Nilsson PM. Olsson AG, et al. Lakartidningen. 2009 Mar 18-24;106(12):854-7. Lakartidningen. 2009. PMID: 19452786 Review. Swedish. No abstract available.
• Ezetimibe plus simvastatin cardiovascular outcomes study program.

  Padial LR. Padial LR. Expert Rev Cardiovasc Ther. 2008 Jan;6(1):17-25. doi: 10.1586/14779072.6.1.17. Expert Rev Cardiovasc Ther. 2008. PMID: 18095904 Review.